1. Ryoo UH. Problems and managements - related with antihypertensive therapy. Hypertension, Seoul, Yeomoon-Gak 1986;193.
2. Yoo WS. Problems with long-term antihypertensive drug therapy. Med Postgraduate 1985;13:265–271.
3. Seki A. Compliance of long-term antihypertensive therapy. Diag and therapy 1985;73:249–252.
4. Yoo WS, Choi SK. A study on the compliance of patients with essential hypertension. Inje Med J 1987;8:27–32.
5. Yoo WS, Choi SK, RHee KJ, Yi KJ, Noh SH. Effect of physician’s intervention on the compliance of patients with essential hypertension. The Korean J of Intern Med 1989;36:237–240.
6. Yoo WS, Kim NW, Noh SH, Rhee KJ, Choi SK, Cho BL. Effect of improvement in insurance coverage on the compliance of patients with essential hypertension. Inje Med J 1990;11:93–97.
7. Yoo WS, Kim YK, Kim JH, Choi SK, Jeon YB. A study on the compliance of patients with essential hypertension IV-Effect of combined strategies provided by physician and insurance. Inje Med J 1991;12:67–71.
8. MRFIT Research Group. Multiple risk factor intervention trial JAMA. 1982;248:1465–1477.
9. Morgan TO, Adams WR, Hodgson M, Gibbend RW. Failure of therapy to improve prognosis in elderly males. Med J Aust 1980;2:27–31.
10. Schoenfield MR, Goldberger E. Hypercholesterolemia induced by thiazide; A pilot study. Curr Ther Res 1964;6:180–184.
11. Tbanaka N, Sakaguchi S, Oshige K, Niimura T, Kanehisa T. Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 1976;25:1071–1075.
12. Jin SB, Rhee YW, Chang SW, Kim KC, Kim SP, Song CS. Effects of dihydrochlorothiazide, propranolol and prazosin on serum lipids in patients with essential hypertension. The Korean Circul J 1985;15:329–336.
13. Yoo WS. Effect of combination therapy of acebutolol with hydrochlorothiazide (Sectral) on the serum lipids of patients with essential hypertension. The Korean Circul J 1984;14:377–383.
14. Kim SJ, Lee JK, Yoo WS. Effects of beta-blockers combined with hydrochlorothiazide on the serum lipids of patients with essential hypertension. Inje Med J 1984;5:431–437.
15. Jeon YB, Kim MH, Choi SK, Yoo WS. Effects of tripamide (Tripamol) on serum lipids and hypertension. The Korean Circul J 1985;15:467–471.
16. Noh SH, Rhee KJ, Choi SK, Yoo WS. The effect of antihypertension and lipid metabolism by long term therapy of captopril and low dose hydrochlorothiazide. Inje Med J 1989;10:1–5.
17. Mancia G, Bertinieri G, Grassi G. Effect of blood pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet 1983;ii:695–697.
18. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988;259:225–228.
19. Yoo WS. Ambulatory blood pressure monitoring. The Korean Circul J 21:805–808.
20. Sung YJ, Kim DH, Choi SK, Yoo WS. Reference values for the ambulatory blood pressure in normotensive Korean young men. Korean Circul J 1992;22:458–462.
21. Yoo WS, Ko WS, Kim KW, Rhee KJ, Choi SK. Clinical assessment of antihypertensive effect of enlapril by ambulatory blood pressure monitoring. Inje Med J 1989;10:133–138.
22. Lyu JC, Yoo WS, Chung KH, Kim HG, Choi SK. Assessment of efficacy of antihypertensive drugs by ambulatory blood pressure monitoring. Inje Med J 1992;13:171–175.
23. Seki A. Management of hypertensive patient after case finding. J Jap Circul Assoc 1983;17:235.
24. Fujii Y. Long term therapy of hypertension. Tokyo: Chugai Med Publ Co, 1988;98.
25. Yoo WS, Woo SJ, Seong YJ, Kim JH, Choi SK, Jeon YB. A study on the withdrawal of the administration of antihypertensive drugs. Korean J Intern Med 1991;41:218–222.